Mini-stomach models that produce acid have been grown from human gastric cells, helping researchers study rare digestive diseases and test precise treatments.

In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide. Subscribe to our ...

Transplanting human gastric organoids engineered to release insulin in diabetic mice reduced hyperglycemia, offering a therapeutic avenue for type 1 diabetes. Researchers had previously reprogrammed ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide. Low insulin levels allow ...

Explore the groundbreaking study on mini-stomach organoids that replicate human stomach regions for advanced research.

A new $3.2 million National Institutes of Health (NIH) R01 grant is helping University of Nevada, Reno School of Medicine (UNR Med) researchers delve into one of the body’s most fascinating processes ...

Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...

Scientists report in Nature using pluripotent stem cells to generate human stomach tissues in a petri dish that produce acid and digestive enzymes. Publishing their findings online Jan. 4, researchers ...